Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Phenotypic and Functional Characterization of Oncohistone Mutations in Breast Cancers

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Homo sapiens

PROVIDER: GSE295988 | GEO | 2025/07/30

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Phenotypic and Functional Characterization of Oncohistone Mutations in Breast Cancers [RNA-seq]

Project description:Although mutations in genes encoding histones display a similar prevalence to that of some other somatic mutations in cancer, the underlying mechanisms by which histone mutations drive tumorigenesis have not been fully explored. Herein, we curated missense mutations occurring in core histone genes in breast cancers using data from MSK-IMPACT and cBioPortal to identify high frequency breast cancer-associated histone gene mutations. We characterized 17 high frequency oncohistone mutations in H2A H2B, and H3 that are enriched in breast cancer samples and occurred at glutamate (E), aspartate (D), serine (S), and arginine (R) residues. Many of these mutants co-occur with PIK3CA mutations in breast cancer samples. The oncohistone mutants were expressed in MCF-7 breast cancer cells or MCF10A mammary epithelial cells and screened for effects on oncogenic phenotypes in a variety of cell- and tumor-based assays (i.e., proliferation, migration, invasion, competitive outgrowth, transformation). In addition, we examined the effects of selected mutants on DNA damage, gene expression, and posttranslational modification of histones (e.g., acetylation, phosphorylation, methylation, ADP-ribosylation). Our results indicate that the collection of oncohistone mutants that we screened have varying phenotypic and functional effects. Some can promote cancer-related phenotypes and may act as potential cancer drivers, with H2B-E76K/Q, H3-E97K, and H3-E105K eliciting strong cancer phenotypes. These observations can be used as a resource to connect biological and molecular outcomes to oncohistones in breast cancers.

2025-07-30 | GSE295718 | GEO

Phenotypic and Functional Characterization of Oncohistone Mutations in Breast Cancers

Project description:Phenotypic and Functional Characterization of Oncohistone Mutations in Breast Cancers

| PRJNA1257087 | ENA

Oncohistone mutations occur at functional sites of regulatory ADP-ribosylation: the role of oncohistone mutations in transcriptional regulation

Project description:This SuperSeries is composed of the SubSeries listed below.

2022-08-02 | GSE180463 | GEO

Phenotypic and Functional Characterization of Oncohistone Mutations in Breast Cancers [RNA-seq]

Project description:Phenotypic and Functional Characterization of Oncohistone Mutations in Breast Cancers [RNA-seq]

| PRJNA1256248 | ENA

Characterization of FOXA1 mutations in breast cancer

Project description:This SuperSeries is composed of the SubSeries listed below.

2020-11-19 | GSE134657 | GEO

Functional characterization of genetic variants associated with upper digestive cancers

Project description:This SuperSeries is composed of the SubSeries listed below.

2024-02-24 | GSE240214 | GEO

The expanding landscape of 'oncohistone' mutations in human cancers.

Project description:Mutations in epigenetic pathways are common oncogenic drivers. Histones, the fundamental substrates for chromatin-modifying and remodelling enzymes, are mutated in tumours including gliomas, sarcomas, head and neck cancers, and carcinosarcomas. Classical 'oncohistone' mutations occur in the N-terminal tail of histone H3 and affect the function of polycomb repressor complexes 1 and 2 (PRC1 and PRC2). However, the prevalence and function of histone mutations in other tumour contexts is unknown. Here we show that somatic histone mutations occur in approximately 4% (at a conservative estimate) of diverse tumour types and in crucial regions of histone proteins. Mutations occur in all four core histones, in both the N-terminal tails and globular histone fold domains, and at or near residues that contain important post-translational modifications. Many globular domain mutations are homologous to yeast mutants that abrogate the need for SWI/SNF function, occur in the key regulatory 'acidic patch' of histones H2A and H2B, or are predicted to disrupt the H2B-H4 interface. The histone mutation dataset and the hypotheses presented here on the effect of the mutations on important chromatin functions should serve as a resource and starting point for the chromatin and cancer biology fields in exploring an expanding role of histone mutations in cancer.

| S-EPMC6512987 | biostudies-literature

Comparative Characterization of 3D Chromatin Organization in Triple-Negative Breast Cancers

Project description:This SuperSeries is composed of the SubSeries listed below.

2022-05-06 | GSE167154 | GEO

Systematic functional characterization of BAF mutations yields novel intra-complex synthetic lethalities

Project description:This SuperSeries is composed of the SubSeries listed below.

2019-04-30 | GSE108390 | GEO

Functional Characterization of Cooperating MGA Mutations in RUNX1::RUNX1T1 Acute Myeloid Leukemia

Project description:This SuperSeries is composed of the SubSeries listed below.

2024-05-15 | GSE253753 | GEO